Stem Cell Transplants May Heal Brain Damage Caused By Parkinson's
the Psychiatry Advisor take:
A recent finding that stem cells can been used to make dopamine cells that were then transplanted into the brains of rats may lay the groundwork for new treatments for Parkinson’s disease.
Malin Palmar, PhD, of the Wallenberg Neuroscience Center at Lund University in Sweden, and colleagues, made the discovery while working with rat models. Parkinson’s is caused by the loss of nerve cells in the brain that produce dopamine, which helps regulate mood and movement.
In their experiments, the researchers killed dopamine-producing neurons in one side of the rats’ brains. Then, human embryonic stem cells that were converted into neurons that produced dopamine were implanted into the brains.
Results showed that after the insertion of the new cells, damage caused during the absence of the neurons was reversed, the researchers reported in the journal Cell Stem Cell. In addition, those cells survived in the long-term, restored dopamine production and functioned in a way similar to dopamine cells in the human brain.
"These cells have the same ability as the brain's normal dopamine cells to not only reach, but also to connect to their target area over longer distances,” Palmar said. “This has been our goal for some time, and the next step is to produce the same cells under the necessary regulations for human use.”
The researchers said human trials of stem-cell-derived neurons could begin as early as 2017.
Stem Cells May Heal Brain Damage Caused By Parkinson's
Stem cells can be used to heal the damage in the brain caused by Parkinson's disease, according to scientists in Sweden. They said their study on rats heralded a "huge breakthrough" towards developing effective treatments.
The disease is caused by the loss of nerve cells in the brain that produce the chemical dopamine, which helps to control mood and movement. To simulate Parkinson's, Lund University researchers killed dopamine-producing neurons on one side of the rats' brains.
They then converted human embryonic stem cells into neurons that produced dopamine. These were injected into the rats' brains, and the researchers found evidence that the damage was reversed.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- FDA Approves Schizophrenia Medication With Digital Ingestion Sensor
- Increased Depression Severity Following Childhood Exposure to Adversity, Risk
- Suboptimal Neuromotor Development Related to Genetic Risk for Schizophrenia
- No Association Between Comorbid Anxiety Disorders, Suicide Attempts
- Cannabidiol Concentration, Labeling Varies Widely in Products Sold Online
- Maintenance rTMS for Treatment-Resistant Depression
- Eye Movement Desensitization and Reprocessing Reduces PTSD Symptoms
- Micronutrients Improve Some Symptoms of ADHD
- Long-Acting Injectable Antipsychotics Delay Schizophrenia Relapse
- Transcranial Stimulation Reduces Auditory Hallucinations in Schizophrenia
- Frequent Migraines Increase Severity of Anxiety, Depression
- Abnormal MRI and CSF Findings May Predict Risk for Alzheimer's Dementia
- Genetic Link Between Obesity Traits, Depression With Atypical Features
- Improved Outcomes for Patients Treated by Own PCP During Hospital Stay
- Patients With Excessive Daytime Sleepiness May Benefit From Sodium Oxybate